EP 3638244 A1 20200422 - PHARMACEUTICAL FORMULATIONS OF XANTHINE OR XANTHINE DERIVATIVES, AND THEIR USE
Title (en)
PHARMACEUTICAL FORMULATIONS OF XANTHINE OR XANTHINE DERIVATIVES, AND THEIR USE
Title (de)
PHARMAZEUTISCHE FORMULIERUNGEN VON XANTHIN ODER XANTHINDERIVATEN UND DEREN VERWENDUNG
Title (fr)
FORMULATIONS PHARMACEUTIQUES DE XANTHINE OU DE DÉRIVÉS DE XANTHINE, ET LEUR UTILISATION
Publication
Application
Priority
- US 201715620430 A 20170612
- US 2018036981 W 20180612
Abstract (en)
[origin: WO2018231739A1] The present invention relates to pharmaceutical formulations comprising xanthine or xanthine derivatives, kits thereof, and methods for treating fibrotic diseases by local administration.
IPC 8 full level
A61K 31/52 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 9/10 (2006.01); A61K 9/107 (2006.01); A61K 31/715 (2006.01); A61P 15/00 (2006.01)
CPC (source: EP KR)
A61K 9/0019 (2013.01 - EP KR); A61K 9/08 (2013.01 - EP KR); A61K 9/5031 (2013.01 - EP KR); A61K 9/5153 (2013.01 - EP KR); A61K 31/417 (2013.01 - KR); A61K 31/472 (2013.01 - KR); A61K 31/52 (2013.01 - EP); A61K 31/522 (2013.01 - KR); A61K 31/5575 (2013.01 - KR); A61K 31/715 (2013.01 - EP KR); A61K 31/728 (2013.01 - KR); A61K 38/4886 (2013.01 - KR); A61K 47/10 (2013.01 - EP); A61K 47/183 (2013.01 - EP); A61K 47/36 (2013.01 - EP); A61P 15/00 (2017.12 - EP); A61P 15/10 (2017.12 - KR)
Citation (search report)
See references of WO 2018231739A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018231739 A1 20181220; AU 2018282741 A1 20191031; CA 3060079 A1 20181220; EP 3638244 A1 20200422; JP 2020523300 A 20200806; KR 20200042458 A 20200423
DOCDB simple family (application)
US 2018036981 W 20180612; AU 2018282741 A 20180612; CA 3060079 A 20180612; EP 18735151 A 20180612; JP 2019566360 A 20180612; KR 20207000912 A 20180612